Biomimetic nanocomposites for bone graft applications

Nanomedicine

Volumn 1, Issue 2, 2006, Pages 177-188

  Chan, Casey K ^a   Sampath Kumar, T S ^b   Liao, Susan ^a   Murugan, Ramalingam ^a   Ngiam, Michelle ^c   Ramakrishnan, Seeram ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^c NONE

Author keywords

Biomimetic; Biomineralization; Bone; Bone grafts; Bone morphogeneic proteins; Nanocomposite; Tissue engineering

Indexed keywords

BIOMIMETIC MATERIAL; NANOCOMPOSITE; NANOPARTICLE;

ANIMAL; BONE TRANSPLANTATION; HUMAN; METHODOLOGY; NANOTECHNOLOGY; REVIEW;

ANIMALS; BIOMIMETIC MATERIALS; BONE TRANSPLANTATION; HUMANS; NANOCOMPOSITES; NANOPARTICLES; NANOTECHNOLOGY;

EID: 34250317609     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/17435889.1.2.177     Document Type: Review

References (76)

1. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN: Bone-graft substitutes: facts, fictions, and applications. J. Bone Joint Surg. Am. 83, 98-103(2001).
2. Carlisle E, Fischgrund JS: Bone morphogenetic proteins for spinal fusion. Spint J. 5, 240S-249S (2005).
3. Enneking WF, Eady JL, Burchardt H: Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. J. Bone Joint Surg. Am. 62(7), 1039-1058 (1980).
4. Webster TJ: Nanophase ceramics as improved bone tissue engineering materials. Am. Ceram. Soc. Bull 82, 23-28 (2003).
5. Younger EM, Chapman MW: Morbidity at bone graft sites. J. Orthop. Trauma 3(3), 192-195 (1989).
6. Yang S, Leong KF, Du Z, Chua CK: The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 7(6), 679-689 (2001).
7. Burg KJL, Porter S, Keilam JF: Biomaterial developments for bone tissue engineering. Biomaterials 21, 2347-2359 (2000).
8. Holy CE, Shoichet MS, Davies JE: Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period. J. Biomed. Mater. Res. 51, 376-382 (2000)
9. Finkemeier CG: Bone-grafting and bone-graft substitutes. J. Bone Joint Surg. Am. 84, 454-464 (2002).
10. Barrack RL: Bone graft extenders, substitutes, and osteogenic proteins. J. Arthroplasty 20(4 Suppl. 2), 94-97 (2005).
11. Le Nihouannen D, Le Guehennec L, Rouillon T et al.: Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 27, 2716-2722 (2006).
12. Giannoudis PV, Dinopoulos H, Tsiridis E: Bone substitutes: an update. Injury 36(Suppl. 3), S20-S27 (2005).
13. Daculsi G, Legeros RZ, Nery E, Lynch K, Kerebel B: Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J. Biomed Mater. Res. 23(8), 883-894 (1989).
14. Kamakura S, Sasano Y, Suzuki O: Synthetic octacalcium phosphate (OCP) is an effective scaffold to regenerate bone. Int. Congr. Ser. 1284, 290-295 (2005).
15. Stubbs D, Deakin M, Chapman-Sheath P et al.: In-vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model. Biomaterials 25, 5037-5044 (2004).
16. Daculsi G: Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 19, 1473-1478 (1998).
17. Sampath Kumar TS, Manjubala I, Gunasekaran J: Synthesis of carbonated calcium phosphate ceramics using microwave irradiation. Biomaterials 21, 1623-1629 (2000).
18. Livingston Arinzeh T, Tran T, Mcalary J, Daculsi G: A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 26, 3631-3638 (2005).
19. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC: Comparison of HEALOS/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30(9), 1001-1007 (2005).
20. Tay BK, Le AX, Heilman M et al.: Use of a collagen-hydroxyapatite matrix in spinal fusion: a rabbit model. Spine 23, 2276-2281 (1998).
21. Chapman MW, Buchok R, Cornell C: Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J. Bone Joint Surg. Am. 79(4), 495-502 (1997).
22. Boden SD, Kang J, Sandhu H, Heller JG: Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - a prospective, randomized clinical pilot trial 2002 Volvo Award in clinical studies. Spine 27(23), 2662-2673 (2002).
23. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC: Comparison of HEALOS/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30(9), 1001-1007 (2005).
24. Martin GJ Jr, Boden SD, Marone MA, Moskovitz PA: Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in non-human primate: important lessons learned regarding dose, carrier and safety. J. Spinal Disord. 12(3), 179-186 (1999).
25. Barnes B, Boden SD, Louis-Ugbo J et al.: Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine 30(10), 1127-1133(2005).
26. Schimandle JH, Boden SD: Bone substitutes for lumbar fusion: present and future. Oper. Tech. Ortho. 7(1), 60-67 (1997).
27. Webster TJ, Ergun C, Doremus RH, Siegel RW Bizios R: Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J. Biornat. Med. Res. 51, 475-483 (2000).
28. Sato M, Webster TJ: Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev. Med. Devices 1(1), 105-114 (2004).
29. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R: Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21, 1803-1810 (2000).
30. Balasundarama G, Sato M, Webster TJ: Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 27, 2798-2805 (2006).
31. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R: Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials 22, 1327-1333 (2001).
32. Catledge SA, Fries MD, Vohra YK et al.: Nanostructured ceramics for biomedical implants. J. Nanosci. Nanotechnol 2(3), 1-20 (2002).
33. Vallet-Regl M: Ceramics for medical applications. J. Chem. Soc. Dalton Tram. 100, 97-108 (2001).
34. Hasegawa M, Doi Y, Uchida A: Cell-mediated bioresorption of sintered carbonate apatite in rabbits. J. Bone Joint Surg. Br. 85B(1), 142-147 (2003).
35. Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S: Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J. Nutr. 130, 216-220 (2000).
36. Hing KA, Saeed S, Annaz B, Buckl and T, Reveil PA: Silicate substitution alters the progression of bone apposition within porous hydroxyapatite bone graft substitutes. 50th Annual Meeting of the Orthopedic Research Society. San Francisco, CA, USA, 7-10 March V29, 1038 (2004).
37. Merry JC, Gibson IR, Best SM, Bonfield W: Synthesis and characterization of carbonate hydroxyapatite. J. Mater. Sci. Mater. Med 9, 779-783 (1998).
38. Porter A, Patel N, Brooks R, Best SM, Rushton N, Bonfield W: Effect of carbonate substitution on the ultrastructural characteristics of hydroxyapatite implants. J. Mater. Sci. Mater. Med. 16, 899-907 (2005).
39. Sato M, Sambito MA, Aslani A, Kalkhoran NM, Slamovich EB, Webster TJ: Increased osteoblast functions on undoped and yttrium-doped nanocrystalline hydroxyapatite coatings on titanium. Biomaterials 27, 2358-2369 (2006).
40. Blokhuis TJ, Termaat MF, den Boer FC, Patka P, Bakker FC. Haarman HJ: Properties of calcium phosphate ceramics in relation to their in vivo behavior. J. Trauma 48(1), 179-186 (2000).
41. Sanchez-Salcedo S, Izquierdo-Barba I, Arcos D, Vallet-Regi M. In-vitro evaluation of potential calcium phosphate scaffolds for tissue engineering. Tissue Eng. 12(2), 279-290 (2006).
42. Ahn ES, Gleason NJ, Nakahira A Ying JY: Nanostructure processing of hydroxyapatite-based bioceramics. Nano Lett. 1(3), 149-153(2001).
43. Lazi S, Zec S, Miljevi N, Milonji S: The effect of temperature on the properties of hydroxyapatite precipitates from calcium hydroxide and phosphoric acid. Thermochim. Acta. 374, 13-22 (2001).
44. Tampieri A, Celotti G, Landi E, Sandri M, Roveri N, Falini G: Biologically inspired synthesis of bone-like composite: self assembled collagen fibers/hydroxyapatite nanocrystals. J. Biomed. Mater. Res. 67A, 618-625 (2003).
45. Fujihara K, Kotaki M, Ramakrishna S: Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers. Biomaterials 26, 4139-4147 (2005).
46. Thomas V, Jagani S, Johnson K et al.: Electrospun bioactive nanocomposite scaffolds of polycaprolactone and nanohydroxyapatite for bone tissue engineering. J. Nanosci. Nanotechnol. 6(2), 487-493 (2006).
47. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL: Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomateriah. 27, 3115-3124(2006).
48. Ito Y, Hasuda H, Kamitakahara M et al.: A composite of hydroxyapatite with electrospun biodegradable nanofibcrs as a tissue engineering material. J. Biosci. Bioeng. 100(1), 43-49 (2005).
49. Fan HS, Wen XT, Tan YF, Wang R, Cao HD, Zhang XD: Compare of electrospinning PLA and PLA/β-TCP scaffold in vitro. PRICM 5: me Fifth Pacific Rim International Conference on Advanced Materials and Processing, PTS 1-5 Mater. Sci. Forum 475-479, 2379-2382, Part 1 (2005).
50. Marouf HA, Quayle AA, Sloan P: In-vitro and in vivo studies with collagen/hydroxyapatite implants. Int. J. Oral Maxilofac. Implants 5(2), 148-154 (1990).
51. Okazaki M, Ohmae H, Takahashi J, Kimura H, Sakuda M: Insolubilized properties of UV-irradiated CO3 aparite-collagen composites. Biomateriah 11, 568-572 (1990).
52. Beniash E, Hartgerink JO, Storrie H, Stendahi JC, Stupp SI: Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomater. 1, 387-397 (2005).
53. Hartgerink JD, Beniash E, Stupp SI: Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294, 1684-1688(2001).
54. Murugan R, Ramakrishna S: Development of nanocomposites for bone grafting. Compos. Sci. Technol. 65, 2385-2406 (2005).
55. Zhang W, Liao SS, Cui FZ: Hierarchical self-assembly of nano-fibrils in mineralized collagen. Chem. Mater. 15, 3221-3226 (2003).
56. Du C, Cui FZ, Zhang W, Feng QL, Zhu XD, de Groot K: Formation of calcium phosphate/collagen composites through mineralization of collagen matrix. J. Biomed Mater. Res. 50, 518-527 (2000).
57. Liao SS, Cui FZ, Zhang W, Feng QL: Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite. J. Biomed. Mater. Res. Appl. Biomater. 69B, 158-165 (2004).
58. Liao SS, Cui FZ, Zhu Y: Osteoblasts adherence and migration into a three-dimensional porous mineralized collagen: nHAC/PLA based composite. J. Bioact. Compat. Polym. 19(2), 117-130 (2004).
59. Liao SS, Guan K, Cui FZ, Shi SS, Sun TS: Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model. Spine 28(17), 1954-1960 (2003).
60. Rhee SH, Tanaka J: Synthesis of a hydroxyapatite/collagen/chondroitin sulfate nanocomposite by a novel precipitation method. J. Am. Ceram. Soc. 84(2), 459-461 (2001).
61. Bigi A, Cojazzi G, Panzavolta S et al.: Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J. Inorg. Biochem. 68, 45-51 (1997).
62. Landi E, Celotti G, Logroscino G, Tampieri A: Carbonated hydroxyapatite as bone substitute. J. Eur. Ceram. Soc. 23, 2931-2937(2003).
63. Goodman S: Wear particulate and osteolysis. Orthop. Clin. North Am. 36(1), 41 (2005)
64. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113(7), 823-839 (2005).
65. Sun TS, Guan K, Shi SS et al.: Effect of nano-hydroxyapadte/colkgen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits. Chin. J. Tmumatol. 7, 18-24 (2004).
66. El-Ghannam A, Ning CQ, Mehta J: Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery. J. Biomed Mater. Res. A 71, 377-390 (2004).
67. Loscertales IG, Barrero A, Guerrero I, Cortijo R, Marquez M, Gafián-Calvo AM: Micro/nano encapsulation via electrified coaxial liquid jets. Science 295, 1695-1698 (2002).
68. Number of patients undergoing hip replacements from 1999-2003 www.aaos.org/wordhtml/rcsearch/stats/hip-all.htm (Accessed May 2006)
69. National Center for Health Statistics. www.cdc.gov/nchs/datayhus/hus05. pdf (Accessed May 2006)
70. Wright Medical Technology Inc. http://wmt.dcv.lunaweb.net/Physicians/ Products/Biologics/CELLPLEXTCPSyntheticCancellousBone.asp (Accessed March 2006)
71. Depuy Spine Inc. www.depuyacromed.com/products/biologicssolutions/tcp.asp (Accessed March 2006)
72. Medtech insight: tissue engineering and cell transplantation: technologies, opportunities, and evolving markets report A401 www.medtechinsight.com/ReportA401.html (Accessed May 2006)
73. OP-1. Summary of safety and probable benefit www.faa.gov/cdrh/pdf2/ H020008b.pdf (Accessed April 2006)
74. OP-1. Summary of safety and probable benefit
75. www.fda.gov/cdrh/pdf/h010002b.pdf (Accessed April 2006)
76. INFUSE. summary of safety and effectiveness data www.fda.gov/cdrh/pdf/ P00O058b.pdf (Accessed April 2006)